Conférences  >  Médecine & Soins de Santé  >  Maladies Infectieuses

In the last years, there is a great concern about the problem of bacterial resistance to antibiotics used in human medicine as well as in veterinary. The use of antibiotics constitutes an important factor for selection of resistance, not only among pathogenic bacteria but also among the commensal ones. Antimicrobial resistance is a major problem in public health due to the possibility in therapeutic failure. The primary objective of this meeting is to bring together researchers involved in antibiotic resistance prevention and control. The meeting will take an integrated approach to research and it will bring about researchers specializing in different subjects related to antibiotic resistance. We expected to present a universal vision of the importance of antimicrobial resistance in different ecosystems and what can be done about it.

Pharmacologie et développement des médicaments,    Épidémiologie

Harvard Medical School

This acclaimed course, which is among the highest-rated Harvard Medical School CME courses, provides comprehensive ID updates for primary care clinicians. PHYSICIANs, NPs, and PAs can rely on this program for 1) Education that ensures state-of-the-art care; 2) Strategies to improve diagnosis, prevention, and treatment; 3) Guidance to incorporate recent advances and new innovations into day-to-day practice. This course provides education to optimize outcomes for patients with common, challenging, and complex infectious diseases. Education is practical, providing answers to the infectious diseases questions primary care clinicians have every day.

Harvard Medical School Postgraduate Medical Education;     Email.: CEPrograms@hms.harvard.edu

Harvard, CME, Immunization, Lyme, COVID-19, infection, vaccine, HIV, MRSA, Hepatitis, UTI, STI, pneumonia, flu, gastroenteritis, travel medicine, respiratory, coronavirus, C. difficile, H. pylori, antibiotics, antibiotic allergy, tuberculosis, respiratory

Médecine (en général), médecine interne,    Formation médicale continue (FMC)

Ashfield Medcomms

HIV Glasgow will take place between 10-13 November 2024 both as an in-person and a virtual meeting. As in previous years, the programme will be of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there have been significant advances in treatment, new challenges have now appeared. This Congress has moved into areas beyond treatment to look at prevention and cure. The role of people living with HIV in treatment decisions and self-management will feature and we look forward to perspectives in the programme from the community.

Event Secretariat;     Email.: hivglasgow@ashfieldmedcomms.com

HIV, Drug Therapy, Infectious Diseases

EMBL Heidelberg

Infectious diseases are among the most prevalent causes of human illness and death in the world. Pathogens infect humans and all life forms on Earth, being able to cross species barriers, thereby adversely impacting human and planetary health. Fundamental research in infection biology is urgently needed to find therapies for longstanding and emerging infectious diseases. The EMBL Conference ‘The next generation in infection biology’ is a platform for late-stage postdoctoral scientists in the field of infection biology to present their work and connect with the leading European institutions in infection biology. The speakers will be chosen for their track record of research accomplishments and their high-reaching future plans. The audience will have the unique opportunity to experience cutting-edge science presented by the rising leaders in this field. The institutional partners will provide discussion and networking opportunities to connect and shape the future league of infection biologists in Europe.

EMBL Events;     Email.: events@embl.de

LInfectionBiology

Meningitis Research Foundation

We are delighted to announce that following the success of our ‘Meningitis spotlight session’ in 2022, our virtual spotlight series is returning on November 26th 2024 13:30-17:00 GMT, and will be completely free to attend remotely via Zoom Webinars. Hosted in the intervening years to our Meningitis Research Foundation conference, our virtual spotlight session provides the ideal opportunity to discover the very latest in meningitis research, hear from world-renowned speakers and participate in interactive discussions.

Senior Research Officer;     Tél.: [08088003344];     Email.: mariuszk@meningitis.org

Meningitis, Vaccination, Genomics, Paediatrics, Healthcare

ESCEO & IOF

The World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025) is a joint Congress of the International Osteoporosis Foundation and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis. The World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025) is dedicated to all aspects of osteoporosis and related bone diseases.

Tél.: [003287852652];     Email.: info@humacom.com

rheumatology, osteoporosis, osteoarthrtisis, orthopedics, endocrinology

Endocrinologie,    Orthopédie

C2P Forum

The World Congress on Vaccines Research and Development, scheduled for April 24-25, 2025, in Paris, France, is set to be a pivotal event in the field of immunology and vaccine science. This prestigious congress will bring together leading researchers, scientists, healthcare professionals, and industry experts from around the globe to discuss the latest advancements and innovations in vaccine research and development.

Tél.: [+1-864-386-8505];     Email.: vaccines@c2presearch.com

Vaccines for New and Emerging Diseases, Bacterial and Viral Vaccines, Vaccines Against Respiratory Diseases (Influenza/COVID), Cancer Vaccines and Immunotherapy, Vaccine Clinical Trials, Vaccines for Antibiotic-Resistant Bacteria, Immune Characterization, Vaccine Adjuvants, Vaccine Technology & Delivery Platforms, Vaccines Safety and Efficacy, Vaccines Manufacturing and Regulatory, Mucosal Vaccines, Pediatric Vaccines, Plant-derived Vaccines, Veterinary Vaccines, Advances in DNA Vaccines, Conjugate Vaccines, HPV Vaccines, Vaccines against STIs, Recombinant Vaccines, Approaches for Vaccine Development, Bioprocessing and Manufacturing, Vaccine Hesitancy and Public Health Communication, One health approach to Vaccines

Immunologie et Allergie,    Génie biomédical

Join us for the European Public Health and Epidemiology Conference on April 28-29, 2025, in Lisbon, Portugal. This enlightening event will feature a panel of distinguished experts in public health and epidemiology. It's a prime opportunity to explore interconnected research fields and learn from industry leaders in the field. We look forward to welcoming you and fostering knowledge exchange and collaboration at this prestigious gathering.

Our esteemed speakers offer vast expertise in global health initiatives and pioneering research in public health and epidemiology. Seize this opportunity to enhance your understanding of One Health and its pivotal role in securing our future.

Tél.: [+1-864-386-8505];     Email.: publichealth@c2presearch.org

Public Health Conferences 2025, Upcoming Public Health Conferences 2025, Epidemiology Conferences 2025, Public Health and Epidemiology Conferences 2025, European Public Health and Epidemiology Conference 2025, Global Health Conferences 2025, Medical Conferences 2025, Top Public Health Conferences, Public Health Meetings 2025.

EMBL Heidelberg

Infectious diseases are among the most prevalent causes of human illness and death in the world. Epidemics & pandemics have shaped human evolution and history, and although for a while there were considered a solved problem for the developed world, the recent past has showed us all why this is not the case. Antimicrobial resistance, global warming, human population size increase, modern lifestyles (urbanization, traveling), decrease of wild-life habitats for pathogen reservoirs all contribute to creating an ideal setting for infectious diseases becoming an even greater challenge in the future. This symposium will bring together experts working on different pathogens (viruses, bacteria, fungi and parasites) and who rarely meet. It will cover a broad range of topics on the host-pathogen interface, highlighting the diversity in mechanisms and the convergence of strategies pathogens use to invade, hijack host machineries, proliferate within the host, cause disease and spread to other hosts. Infection biologists using systems biology, population genomics, genetics, cell and tissue biology, biochemistry and structural biology will meet to present the state-of-the-art of different fields. The emerging realisation that infections are often polymicrobial, pathogens can be opportunistic and can already reside for years as benign in our body, and that the microbiome can greatly impact infection onset and progress will provide a common thread of discussion across fields of different pathogenic agents. Discussions will fertilise transfer of technologies and know-how across fields, and set the ground for developing new strategies to tackle current bottlenecks in our ability to treat infections.

Catherine Casas-Saavedra;     Email.: catherine.casas@embl.de

Iris Scientific Group is excited to announce the upcoming "Infectious Diseases Congress 2025 (IDC 2025)", set against the backdrop of Paris, a dynamic hub of innovation and culture. Scheduled from June 19-20, 2025, this conference promises an engaging and enlightening experience for attendees and contributors alike. Recognizing the evolving global landscape, IDC 2025 is designed as a Hybrid Event, allowing participants to engage either in-person at Paris, France or Virtually, ensuring accessibility to a worldwide audience. The conference theme, "Harnessing Digital Health: Innovations in Infectious Disease Surveillance and Management," underscores our commitment to exploring transformative digital technologies in disease prevention and control.

EMBL Heidelberg

Human microbiota – the collection of microbes living in and on our body – have a significant impact on human health and well-being. They have been associated with numerous diseases, yet we are still far from understanding their role in the context of lifestyle and genetics. Various initiatives are underway around the world to survey the human microbiota at several body sites, characterise them, understand their interactions with the human hosts, elucidate their role in diseases, and design possible therapeutic or dietary interventions. There is a new wave of studies mining the human microbiota for health-relevant bioactive compounds, for characterising specific microbial strains and for cataloguing the human microbiota from all across the globe. This conference will provide plentiful opportunities for researchers to learn about and to connect to important developments in studying the human microbiota.

EMBL Events;     Email.: events@embl.de